Contaminated Generic Non-approved Remdesivir Vials: New Risk in Treatment of COVID-19

G. Aygun, O. Kayhan, Fatouma Moustapha Houssein, S. Urkmez, A. Kurt, B. Mete
{"title":"Contaminated Generic Non-approved Remdesivir Vials: New Risk in Treatment of COVID-19","authors":"G. Aygun, O. Kayhan, Fatouma Moustapha Houssein, S. Urkmez, A. Kurt, B. Mete","doi":"10.36519/idcm.2020.0031","DOIUrl":null,"url":null,"abstract":"The original trademark name of remdesivir with proven and approved efficacy developed by Gilead is Veklury®. Veklury® is licenced in over 50 countries around the world, including the United States, European Union, Japan, Canada, Australia. Veklury® has not yet been licenced by the Ministry of Health in Turkey. Gilead supplied 17 378 vials of Veklury® to the Health of Ministry of Turkey free of charge. However, Gilead announced that illegal products which are likely to contain remdesivir have been entered our country and sold on the black market (3).","PeriodicalId":11964,"journal":{"name":"European Journal of Clinical Microbiology and Infectious Diseases","volume":"31 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology and Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36519/idcm.2020.0031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The original trademark name of remdesivir with proven and approved efficacy developed by Gilead is Veklury®. Veklury® is licenced in over 50 countries around the world, including the United States, European Union, Japan, Canada, Australia. Veklury® has not yet been licenced by the Ministry of Health in Turkey. Gilead supplied 17 378 vials of Veklury® to the Health of Ministry of Turkey free of charge. However, Gilead announced that illegal products which are likely to contain remdesivir have been entered our country and sold on the black market (3).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
受污染的非批准仿制瑞德西韦小瓶:治疗COVID-19的新风险
由吉利德开发的经证实有效的瑞德西韦原商标名称为Veklury®。Veklury®在全球50多个国家获得许可,包括美国,欧盟,日本,加拿大,澳大利亚。Veklury®尚未获得土耳其卫生部的许可。吉利德向土耳其卫生部免费提供17 378瓶Veklury®。然而,吉利德宣布,可能含有remdesivir的非法产品已经进入我国并在黑市上销售(3)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comparison of 28-Day Mortality Between Hospital- and Community-Acquired Influenza Patients Long-Term Symptoms and Quality of Life in Persons with COVID-19 B Cell Subtypes in Individuals Received mRNA or Inactivated Vaccine Boosters After Fully Vaccinated with CoronaVac: A Longitudinal Study Centenary of the Republic and 90th Anniversary of the University Reform in Türkiye COVID-19: An Update on Epidemiology, Prevention and Treatment, September-2023
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1